Latest filing published 04 Mar 2025 for Aclaris Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph Monahan: trading record in brief
Joseph Monahan (senior executive) discloses dealings in Aclaris Therapeutics, Inc. to SEC (Form 4). Between 1 June 2021 and 1 March 2025, the trades on record add up to 43 filings.
Sales make up the whole of the open-market record (13 sales, €1.9M). The rest of the record consists of 9 share grants and 20 option exercises.
Most recently, on 4 March 2025, the filings show an option exercise in Aclaris Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph Monahan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 sharesCommon StockSEC:0001415889-25-006495:0
- 7,500 sharesCommon StockSEC:0001415889-25-002940:0
- 14,750 sharesCommon StockSEC:0001415889-25-002940:1
- 11,317 shares@ US$2.482.2% of flowCommon StockSEC:0001415889-25-002940:2
- 73,750 sharesCommon StockSEC:0001415889-25-000624:0
- 15,000 shares0Common StockSEC:0001415889-24-029092:0
- 50,000 sharesCommon StockSEC:0001209191-24-004402:0
- 7,500 sharesCommon StockSEC:0001209191-24-002840:0
- 6,000 shares@ US$5.07672.3% of flowCommon StockSEC:0001209191-23-053558:0
- 6,000 shares@ US$7.31583.3% of flowCommon StockSEC:0001209191-23-046905:0
- 6,000 shares@ US$10.27714.6% of flowCommon StockSEC:0001209191-23-039070:0
- 13,750 sharesCommon StockSEC:0001209191-23-016065:0
- 5,000 shares@ US$13.06215.0% of flowCommon StockSEC:0001209191-23-010658:0
- 5,000 shares@ US$15.88236.1% of flowCommon StockSEC:0001209191-22-061695:0
- 5,000 shares@ US$15.98156.7% of flowCommon StockSEC:0001209191-22-054073:0
- 30,000 shares@ US$16.27660.072% mcap53.5% of flowCommon StockSEC:0001209191-22-025032:0
- 27,165 shares@ US$15.711531.8% of flowCommon StockSEC:0001209191-22-018501:0
- 13,750 sharesCommon StockSEC:0001209191-22-015829:0
- 383 shares@ US$12.68180.4% of flowCommon StockSEC:0001209191-22-008860:0
- 1,050 sharesCommon StockSEC:0001209191-22-006836:0
- 2,333 sharesCommon StockSEC:0001209191-21-054530:0
- 50,000 sharesCommon StockSEC:0001209191-21-037478:0
22 of 22 declarations
